company background image
CTE

Cryosite ASX:CTE Stock Report

Last Price

AU$0.75

Market Cap

AU$36.6m

7D

-1.3%

1Y

114.3%

Updated

01 Dec, 2022

Data

Company Financials
CTE fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance6/6
Financial Health5/6
Dividends0/6

CTE Stock Overview

Cryosite Limited offers outsourced clinical trials logistic services in Australia.

Cryosite Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Cryosite
Historical stock prices
Current Share PriceAU$0.75
52 Week HighAU$0.87
52 Week LowAU$0.35
Beta0.46
1 Month Change13.64%
3 Month Change5.63%
1 Year Change114.29%
3 Year Change1,288.89%
5 Year Change455.56%
Change since IPO70.46%

Recent News & Updates

Should You Be Adding Cryosite (ASX:CTE) To Your Watchlist Today?

Aug 19
Should You Be Adding Cryosite (ASX:CTE) To Your Watchlist Today?

Recent updates

Should You Be Adding Cryosite (ASX:CTE) To Your Watchlist Today?

Aug 19
Should You Be Adding Cryosite (ASX:CTE) To Your Watchlist Today?

Do Cryosite's (ASX:CTE) Earnings Warrant Your Attention?

May 02
Do Cryosite's (ASX:CTE) Earnings Warrant Your Attention?

Shareholder Returns

CTEAU Life SciencesAU Market
7D-1.3%-2.2%1.3%
1Y114.3%-46.6%-1.1%

Return vs Industry: CTE exceeded the Australian Life Sciences industry which returned -45.4% over the past year.

Return vs Market: CTE exceeded the Australian Market which returned -2% over the past year.

Price Volatility

Is CTE's price volatile compared to industry and market?
CTE volatility
CTE Average Weekly Movement9.8%
Life Sciences Industry Average Movement9.8%
Market Average Movement9.0%
10% most volatile stocks in AU Market16.0%
10% least volatile stocks in AU Market4.1%

Stable Share Price: CTE is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 10% a week.

Volatility Over Time: CTE's weekly volatility (10%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
199922John Hogghttps://www.cryosite.com

Cryosite Limited offers outsourced clinical trials logistic services in Australia. It operates through two segments, Clinical Trials and Biological Services Logistics, and Cord Blood and Tissues Storage. The Clinical Trials and Biological Services Logistics segment provides specialist temperature-controlled storage, labelling, status management, secondary packaging, schedule drug distribution, destruction, returns management, comparator sourcing, import, export, validated transport, and biological storage solutions to the clinical trials, and research and pharmaceutical industry.

Cryosite Limited Fundamentals Summary

How do Cryosite's earnings and revenue compare to its market cap?
CTE fundamental statistics
Market CapAU$36.61m
Earnings (TTM)AU$1.36m
Revenue (TTM)AU$11.76m

26.8x

P/E Ratio

3.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
CTE income statement (TTM)
RevenueAU$11.76m
Cost of RevenueAU$4.92m
Gross ProfitAU$6.84m
Other ExpensesAU$5.47m
EarningsAU$1.36m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)0.028
Gross Margin58.16%
Net Profit Margin11.60%
Debt/Equity Ratio0%

How did CTE perform over the long term?

See historical performance and comparison

Dividends

1.3%

Current Dividend Yield

36%

Payout Ratio